Clinical characteristics and outcomes of atrial fibrillation and flutter at the Aga Khan University Hospital, Nairobi

Cardiovascular Journal of Africa

Volumn 24, Issue 2, 2013, Pages 6-9

  Shavadia, Jay ^a   Yonga, Gerald ^a   Mwanzi, Sitna ^a   Jinah, Ashna ^a   Moriasi, Abednego ^a   Otieno, Harun ^a  

^a AGA KHAN UNIVERSITY   (Kenya)

Author keywords

Atrial fibrillation; Clinical characteristics; Kenya; Outcomes

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; FLECAINIDE; PROPAFENONE; SOTALOL;

ADULT; AFRICA; AGED; ALCOHOL CONSUMPTION; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DIZZINESS; FAINTNESS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART FAILURE; HEART PALPITATION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; HYPERTENSION; HYPERTHYROIDISM; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PAROXYSMAL HEART ATRIUM FIBRILLATION; PRESCRIPTION; RETROSPECTIVE STUDY; RHEUMATIC HEART DISEASE; THROMBOEMBOLISM; UNIVERSITY HOSPITAL; VALVULAR HEART DISEASE;

AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; COMORBIDITY; FEMALE; GUIDELINE ADHERENCE; HOSPITALS, UNIVERSITY; HUMANS; KENYA; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84875899457     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2012-064     Document Type: Article

References (13)

1. Heeringa J, Kuip DVD, Hofman A, Kors J, Herpen GV, Stricker B, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006; 27: 949-953.
2. Lloyd-Jones D, Wang T, Leip E, Larson M, Levy D, Vasan R, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004; 110(9): 1042-1046.
3. Crijns H, Camm J, Diener H, Goette A, Hindricks G, Hohnloser S, et al. Outcome parameters for trials in atrial fibrillation: executive summary. Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence Network (AFNET) and the European Heart Rhythm Association (EHRA). Eur Heart J 2007; 28: 2803-2817.
4. Stewart S, Hart C, Hole D, McMurray J. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002; 113(5): 359-364.
5. Thrall G, Lane D, Carroll D, Lip G, et al. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med 2006; 119(5): 448.e1-e19.
6. Jamison D, Breman J, Measham A, Alleyne G, Claeson M, Evans D, et al. Disease Control Priorities in Developing Countries. New York: Oxford University, 2006.
7. Ntep-Gweth M, Zimmermann M, Meiltz A, Kingue S, Ndobo P, Urban P, et al. Atrial fibrillation in Africa: clinical characteristics, prognosis, and adherence to guidelines in Cameroon. Europace 2010; 12(4): 482-487.
8. Sliwa K, Carrington M, Klug E, Opie L, Lee G, Ball J, et al. Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: insights from the Heart of Soweto Study. Heart 2010; 96(23): 1878-1882.
9. Gage B, Waterman AD, Shannon W, Boechler M, Rich M, Radford M. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. J Am Med Assoc 2001; 285: 2864-2870.
10. Healey J, Connolly S. Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. Am J Cardiol 2003; 91(10A): 9G-14G.
11. Eloi M, Phalla O, David C, Beatriz F, Ana O, Dinesh J, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007; 357: 470-476.
12. Anabwani G, Amoa A, Muita A. Epidemiology of rheumatic heart disease among primary school children in western Kenya. Int J Cardiol 1989; 23(2): 249-252.
13. Lip G, Nieuwlaat R, Pisters R, Lane D, Crijns H. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137: 263-272.